REGIONAL ALLOGENEIC MESOTHELIN-TARGETED CAR (RAMCAR) T-CELL THERAPY FOR ESOPHAGEAL CANCER: CLINICAL TRIAL PREPARATION AND PHASE 1 CLINICAL TRIAL
$1,651,948FY2021Defense Health AgencyDOD
Sloan-Kettering Institute For Cancer Research
Sloan-Kettering Institute For Cancer Research